<DOC>
	<DOCNO>NCT00126399</DOCNO>
	<brief_summary>The objective study evaluate safety efficacy 40 mg doxycycline controlled-release capsule administer daily treatment rosacea compare placebo .</brief_summary>
	<brief_title>A Clinical Trial Determine Effects 40 Mg Doxycycline Versus Placebo Control Treatment Rosacea</brief_title>
	<detailed_description />
	<mesh_term>Rosacea</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<criteria>Main Healthy patient rosacea Males female ≥18 year age 10 40 papule pustule ≤2 nodule Score 2 4 IGA Presence telangiectasia Moderate severe erythema Main Use topical acne treatment topical systemic antibiotic Use systemic retinoids within 90 day baseline Use investigational drug within 90 day baseline Pregnant nursing woman Women childbearing potential use adequate form contraception Change method contraception within 4 month baseline Known hypersensitivity tetracycline Surgeries bypass exclude duodenum achlorhydria</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2005</verification_date>
	<keyword>rosacea</keyword>
	<keyword>acne rosacea</keyword>
</DOC>